UK markets closed
  • NIKKEI 225

    28,226.08
    +257.09 (+0.92%)
     
  • HANG SENG

    18,736.44
    +139.21 (+0.75%)
     
  • CRUDE OIL

    81.41
    +0.86 (+1.07%)
     
  • GOLD FUTURES

    1,817.40
    +57.50 (+3.27%)
     
  • DOW

    34,395.01
    -194.76 (-0.56%)
     
  • BTC-GBP

    13,839.23
    -169.31 (-1.21%)
     
  • CMC Crypto 200

    401.44
    -4.71 (-1.16%)
     
  • ^IXIC

    11,482.45
    +14.45 (+0.13%)
     
  • ^FTAS

    4,141.04
    +1.39 (+0.03%)
     

Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2022 Edition

ReportLinker
ReportLinker

Summary This expert trend report is a comprehensive look at the finished commercial dose contract manufacturing landscape in 2022, including analysis of dose CMO M&A activity, market size and share.

New York, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Contract Pharmaceutical Dose Manufacturing Industry: Composition, Size, Market Share and Outlook - 2022 Edition" - https://www.reportlinker.com/p06176289/?utm_source=GNW
It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

This expert trend report is a comprehensive look at the finished dose contract manufacturing landscape in 2022, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope
This report gives an important expert quantitative analysis on the commercial contract dose manufacturing industry.

Findings are based on the industry’s most comprehensive database of the dose CMO industry (Contract Service Providers Database). This analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 21 figures throughout the report illustrate major points and trends. This report is required reading for -
- CMO executives and strategic decision-makers: to improve understanding of the dose CMO industry and provide a critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Private equity investors: they can gain a deeper understanding of the dose CMO market and important insights for identifying potential investment targets.

Reasons to Buy
This report will enable the user to answer the following questions -
- What is the geographic reach of commercial dose CMOs?
- What are the 2021 revenues generated by the commercial contract dose manufacturing industry?
- What are the components of revenue change for contract dose manufacturers?
- What is the breakdown of 2021 revenues by different dosage forms?
- What are the characteristics of the largest dose CMOs?
- How did the revenue growth of Contract Dose manufacturers in 2021 compare to Contract API manufacturers?
- What is the outlook for the dose CMO industry?
- What is the outlook for COVID-19 products?
Read the full report: https://www.reportlinker.com/p06176289/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001